Evidence map›Paper›PMID 31497046›Full record

ArticlePostepy w kardiologii interwencyjnej = Advances in interventional cardiology2019

Short-term stent coverage of second-generation zotarolimus-eluting durable polymer stents: Onyx one-month optical coherence tomography study.

Tomasz Roleder, Elvin Kedhi, Balazs Berta, Pawel Gasior, Wojciech Wanha, Magda Roleder, Joanna Fluder, Grzegorz Smolka, Andrzej Ochala, Wojciech Wojakowski

Open access · goldAbstract read
In one paragraph

Article in Postepy w kardiologii interwencyjnej = Advances in interventional cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Personalized Antithrombotic Therapy After Percutaneous Coronary Intervention: A Systematic Review of Risk-Stratified Approaches.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2026
    Pooled it
  2. Trial
  3. Article
  4. Review
  5. A prospective, multicentre first-in-man study of the polymer-free ultrathin-strut BIOrapid stent (BIOVITESSE).EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2022
    Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Tomasz RolederDepartment of Cardiology and Structural Heart Diseases, 3 Division of Cardiology, Medical University of Silesia, Katowice, Poland.
Elvin KedhiIsala Haartcentrum, Zwolle, Netherlands.
Balazs BertaIsala Haartcentrum, Zwolle, Netherlands.
Pawel GasiorDepartment of Cardiology and Structural Heart Diseases, 3 Division of Cardiology, Medical University of Silesia, Katowice, Poland.
Wojciech WanhaDepartment of Cardiology and Structural Heart Diseases, 3 Division of Cardiology, Medical University of Silesia, Katowice, Poland.
Magda RolederDepartment of Cardiology and Structural Heart Diseases, 3 Division of Cardiology, Medical University of Silesia, Katowice, Poland.
Joanna FluderDepartment of Cardiology and Structural Heart Diseases, 3 Division of Cardiology, Medical University of Silesia, Katowice, Poland.
Grzegorz SmolkaDepartment of Cardiology and Structural Heart Diseases, 3 Division of Cardiology, Medical University of Silesia, Katowice, Poland.
Andrzej OchalaDepartment of Cardiology and Structural Heart Diseases, 3 Division of Cardiology, Medical University of Silesia, Katowice, Poland.
Wojciech WojakowskiDepartment of Cardiology and Structural Heart Diseases, 3 Division of Cardiology, Medical University of Silesia, Katowice, Poland.
Medical University of Silesia · PLIsala · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTo date the early strut coverage with the second-generation durable-polymer ONYX zotarolimus-eluting stent (O-ZES) is unknown.

aimOptical coherence tomography (OCT) assessed the strut coverage of O-ZES at thirty-day follow-up. MATERIAL AND

methodsOCT was performed after implantation and at 1-month follow-up in 15 patients treated with O-ZES.

resultsMean patient age was 67 ±7 years (73% males). The clinical presentation consisted of acute coronary syndromes (

conclusionsThe second-generation durable polymer O-ZES showed favorable vessel healing at 30-day OCT follow-up.

Indexed as

1-month follow-upoptical coherence tomographyvessel healingzotarolimus-eluting stent

Identifiers

PMID31497046
PMCPMC6727229
OpenAlexW2953462699

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.